It has been reported that corticosteroids did not prevent TGFβ-induced collagen I production by ASM cells from individuals with or without asthma [71], and this suggests that PPARγ agonists may have a therapeutic advantage over corticosteroids in the regulation of lung fibrosis. The gene discussed is PPARG; the disease is asthma.